Generation of insulin-expressing cells from mouse embryonic stem cells

Biochem Biophys Res Commun. 2005 Mar 11;328(2):399-403. doi: 10.1016/j.bbrc.2004.12.183.

Abstract

The therapeutic potential of transplantation of insulin-secreting pancreatic beta-cells has stimulated interest in using pluripotent embryonic stem (ES) cells as a starting material from which to generate insulin secreting cells in vitro. Mature beta-cells are endodermal in origin so most reported differentiation protocols rely on the identification of endoderm-specific markers. However, endoderm development is an early event in embryogenesis that produces cells destined for the gut and associated organs in the embryo, and for the development of extra-embryonic structures such as the yolk sac. We have demonstrated that mouse ES cells readily differentiate into extra-embryonic endoderm in vitro, and that these cell populations express the insulin gene and other functional elements associated with beta-cells. We suggest that the insulin-expressing cells generated in this and other studies are not authentic pancreatic beta-cells, but may be of extra-embryonic endodermal origin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation / physiology*
  • Cells, Cultured
  • DNA-Binding Proteins / biosynthesis
  • Endoderm / cytology
  • Endoderm / metabolism
  • Gene Expression Regulation, Developmental / physiology
  • Insulin / biosynthesis*
  • Islets of Langerhans / cytology*
  • Islets of Langerhans / metabolism*
  • Mice
  • Octamer Transcription Factor-3
  • Stem Cells / cytology*
  • Stem Cells / metabolism*
  • Transcription Factors / biosynthesis

Substances

  • DNA-Binding Proteins
  • Insulin
  • Octamer Transcription Factor-3
  • Pou5f1 protein, mouse
  • Transcription Factors